Cross-reactive antibodies against monkeypox virus exist in the population immunized with vaccinia Tian Tan strain in China

Adler, 2022, Clinical features and management of human monkeypox: a retrospective observational study in the UK, Lancet Infect. Dis., 22, 1153, 10.1016/S1473-3099(22)00228-6 Alakunle, 2020, Monkeypox virus in Nigeria: infection biology, epidemiology, and evolution, Viruses, 12, 10.3390/v12111257 Altayb, 2022, Fludarabine, a potential DNA-dependent rna polymerase inhibitor, as a prospective drug against monkeypox virus: a computational approach, Pharmaceuticals (Basel), 15, 10.3390/ph15091129 Buchman, 2010, A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge, Vaccine, 28, 6627, 10.1016/j.vaccine.2010.07.030 Bunge, 2022, The changing epidemiology of human monkeypox-a potential threat? A systematic review, PLoS Negl. Trop. Dis., 16, 10.1371/journal.pntd.0010141 Coppeta, 2019, Persistence of immunity for hepatitis b virus among heathcare workers and italian medical students 20 years after vaccination, Int. J. Environ. Res. Public Health, 16, 10.3390/ijerph16091515 Criscuolo, 2023, Smallpox vaccination-elicited antibodies cross-neutralize 2022-monkeypox virus clade ii, J. Med. Virol., 95, 10.1002/jmv.28643 Dine, 2004, Persistence of vaccine-induced antibody to measles 26-33 years after vaccination, J. Infect. Dis., 189, S123 Edghill-Smith, 2005, Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus, Nat. Med., 11, 740, 10.1038/nm1261 Gilchuk, 2016, Cross-neutralizing and protective human antibody specificities to poxvirus infections, Cell, 167 Gushchin, 2022, Estimation of anti-orthopoxvirus immunity in Moscow residents and potential risks of spreading monkeypox virus, Front. Immunol., 13, 1023164, 10.3389/fimmu.2022.1023164 Hammarlund, 2003, Duration of antiviral immunity after smallpox vaccination, Nat. Med., 9, 1131, 10.1038/nm917 Hammarlund, 2017, Plasma cell survival in the absence of b cell memory, Nat. Commun., 8, 1781, 10.1038/s41467-017-01901-w Hraib, 2022, The outbreak of monkeypox 2022: An overview, Ann. Med. Surg. (Lond.), 79 Huang, 2022, Isolation and characterization of monkeypox virus from the first case of monkeypox - Chongqing municipality, China, 2022, China CDC Wkly, 4, 1019, 10.46234/ccdcw2022.206 Ilchmann, 2023, One- and two-dose vaccinations with modified vaccinia Ankara-bavarian nordic induce durable b-cell memory responses comparable to replicating smallpox vaccines, J. Infect. Dis., 227, 1203, 10.1093/infdis/jiac455 Katzelnick, 2021, Dengue and zika virus infections in children elicit cross-reactive protective and enhancing antibodies that persist long term, Sci. Transl. Med., 13, eabg9478, 10.1126/scitranslmed.abg9478 Kotaki, 2022, Japanese encephalitis DNA vaccines with epitope modification reduce the induction of cross-reactive antibodies against dengue virus and antibody-dependent enhancement of dengue virus infection, Vaccines (Basel), 10 Kwanchum, 2017, Duration of neutralizing antibody persisting in thai individuals after childhood vaccination against smallpox, Asian Pac. J. Allergy Immunol., 35, 239 Li, 2011, Cross protection against lethal west nile virus challenge in mice immunized with recombinant e protein domain iii of japanese encephalitis virus, Immunol. Lett., 138, 156, 10.1016/j.imlet.2011.04.003 Li, 1994, Study on the level of vaccinia virus igg antibody in different age groups, Prevent. Med. Inform. J., 129 Ma Xiang, 2022, From smallpox to monkeypox, how to tackle the monkeypox challenge?, Chinese Clin. J. Pract. Pediat., 37, 961 McCollum, 2014, Human monkeypox, Clin. Infect. Dis., 58, 260, 10.1093/cid/cit703 Pedroso, 2019, Cross-protection of dengue virus infection against congenital zika syndrome, northeastern Brazil, Emerg. Infect. Dis., 25, 1485, 10.3201/eid2508.190113 Plotkin, 2008, Vaccines: correlates of vaccine-induced immunity, Clin. Infect. Dis., 47, 401, 10.1086/589862 Raccagni, 2023, Breakthrough monkeypox infection among individuals previously immunized with smallpox or monkeypox vaccination, J. Inf. Secur., 86, 154 Sanz-Munoz, 2023, Possible mpox protection from smallpox vaccine-generated antibodies among older adults, Emerg. Infect. Dis., 29, 656, 10.3201/eid2903.221231 Stittelaar, 2005, Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus, J. Virol., 79, 7845, 10.1128/JVI.79.12.7845-7851.2005 Swanstrom, 2016, Dengue virus envelope dimer epitope monoclonal antibodies isolated from dengue patients are protective against zika virus, mBio, 7 Taub, 2008, Immunity from smallpox vaccine persists for decades: a longitudinal study, Am. J. Med., 121, 1058, 10.1016/j.amjmed.2008.08.019 Theves, 2016, History of smallpox and its spread in human populations, Microbiol. Spectr., 4, 10.1128/microbiolspec.PoH-0004-2014 Wang, 2019, Cross-protection against four serotypes of dengue virus in mice conferred by a zika DNA vaccine, Front. Cell. Infect. Microbiol., 9, 147, 10.3389/fcimb.2019.00147 Wang, 2020, Neutralizing antibody rather than cellular immune response is maintained for nearly 20 years among japanese encephalitis sa14-14-2 vaccinees in an endemic setting, Infect. Genet. Evol., 85, 10.1016/j.meegid.2020.104476 Xiang, 2022, Monkeypox virus emerges from the shadow of its more infamous cousin: family biology matters, Emerg. Microbes. Infect., 11, 1768, 10.1080/22221751.2022.2095309 Yoshikawa, 2021, Third-generation smallpox vaccine strain-based recombinant vaccines for viral hemorrhagic fevers, Vaccine, 39, 6174, 10.1016/j.vaccine.2021.09.001 Zaeck, 2023, Low levels of monkeypox virus-neutralizing antibodies after mva-bn vaccination in healthy individuals, Nat. Med., 29, 270, 10.1038/s41591-022-02090-w Zhou, 2020, Dengue virus envelope protein domain iii-elicited antibodies mediate cross-protection against zika virus in a mouse model, Virus Res., 278, 10.1016/j.virusres.2020.197882